VKTX vs WELL · $3.97B cap vs P/E 100, rev $10.84B
Viking Therapeutics Inc (VKTX) versus Welltower Inc (WELL) — a side-by-side from cached financials, not a winner call.
Viking Therapeutics Inc (VKTX) is a biotechnology company listed on US.
Welltower Inc (WELL) is a reit - healthcare facilities company listed on NYSE.
Latest reported VKTX revenue for 2026-06-30 was $0. Net income was -$286.3M. VKTX currently screens at market cap $3.97B.
Latest reported WELL revenue for 2025-12-31 was $10.84B. Net income was $936.8M. Revenue was up 35.6% from 2024-12-31 to 2025-12-31. WELL currently screens at market cap $145.81B and trailing P/E 99.8.
VKTX currently screens at market cap $3.97B. WELL currently screens at market cap $145.81B and trailing P/E 99.8.
Not investment advice. Open the VKTX and WELL stock pages for the full models.
Not investment advice.